<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: BioVex Raises $40M for Cancer-Fighting Virus</title>
	<atom:link href="http://www.xconomy.com/boston/2009/03/30/biovex-raises-40m-for-cancer-fighting-virus/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/03/30/biovex-raises-40m-for-cancer-fighting-virus/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:08:02 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Mark Tholen</title>
		<link>http://www.xconomy.com/boston/2009/03/30/biovex-raises-40m-for-cancer-fighting-virus/comment-page-1/#comment-53841</link>
		<dc:creator>Mark Tholen</dc:creator>
		<pubDate>Fri, 17 Apr 2009 04:47:56 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=18058#comment-53841</guid>
		<description>I am stage 4 melanoma and doing IL-2... This gives me hope.  Thanks for the good work Biovex.
Dr Mark Tholen</description>
		<content:encoded><![CDATA[<p>I am stage 4 melanoma and doing IL-2… This gives me hope.  Thanks for the good work Biovex.<br />
Dr Mark Tholen</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Money Here, Money There: Today&#8217;s Financings &#38; Deals &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</title>
		<link>http://www.xconomy.com/boston/2009/03/30/biovex-raises-40m-for-cancer-fighting-virus/comment-page-1/#comment-52337</link>
		<dc:creator>Money Here, Money There: Today&#8217;s Financings &#38; Deals &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</dc:creator>
		<pubDate>Tue, 31 Mar 2009 01:19:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=18058#comment-52337</guid>
		<description>[...] Biovex convinced investors to pump in $40M in a Series F for its GM-CSF viral therapy to treat melanoma. Investors included Forbion Capital Partners, Credit Agricole Private Equity, Innoven Partners, New Science Ventures, Triathlon Medical Venture Partners, and Scottish Equity Partners. [Xconomy] [...]</description>
		<content:encoded><![CDATA[<p>[...] Biovex convinced investors to pump in $40M in a Series F for its GM-CSF viral therapy to treat melanoma. Investors included Forbion Capital Partners, Credit Agricole Private Equity, Innoven Partners, New Science Ventures, Triathlon Medical Venture Partners, and Scottish Equity Partners. [Xconomy] [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

